Biovariance GmbH

Biovariance GmbH is an SME in Tirschenreuth, Germany that has taken part in 2 EU-funded projects since 2020, receiving €548k in EU funding.

EU funding received€548k
EU projects2
As coordinator0
Running now1
First EU project2020
Latest project2024
CountryGermany
EU registration (PIC)946599721
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Biovariance GmbH's own share of each project, not the project's full budget.

  • Horizon Europe€299k · 1 project
  • Horizon 2020€249k · 1 project

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • BEATsepPartner

    Biomarkers established to stratify sepsis long-term adverse effects to improve patients’ health and quality of life

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €299ktheir share
  • REVERTPartner

    taRgeted thErapy for adVanced colorEctal canceR paTients

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €249ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • databases
  • immunology
  • oncology
  • pathophysiology
  • software

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime